Product
Raltitrexed
3 clinical trials
3 indications
Indication
Colorectal CancerIndication
Recurrent Rectal CancerIndication
Advanced Metastatic Colorectal CancerClinical trial
A Single-center, Single-arm, Open-label Clinical Study of Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard TherapyStatus: Active (not recruiting), Estimated PCD: 2024-01-01
Clinical trial
Hypofractionated Radiotherapy Combined With Chemotherapy and Toripalimab for Locally Recurrent Rectal Cancer: a Single-arm, Two-cohort, Phase II Trial (TORCH-R)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Raltitrexed Combined With Irinotecan (SALIRI) Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer (mCRC) : an Open-label, Multi-center, and Prospective StudyStatus: Recruiting, Estimated PCD: 2023-06-30